skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I follow Jason Donville and like 5iresearch recommends similar tech companies as 5i using "the rule of 40". Do you use this rule? Other than his fairly transparent newsletter, is there any way to see exactly what his holdings are in the DKAM Capital Ideas fund?
Read Answer Asked by David on March 23, 2021
Q: I’m adding to a partially established portfolio (growth-oriented, long-term). I’m interested both in taking advantage of the recent tech downturn (although not too much, as I’m already somewhat tech-heavy) and in further diversifying. Two questions:

1. I own partial positions in the following securities and am looking to add more. Could you rank them in your order of preference for purchasing now? Any you’d avoid buying now?

WELL, SHOP, ATZ, STC, PHO, ENGH, KXS

2. I’m considering buying positions in the following new securities (not easily comparable, I know), with a view to diversity and growth, as well as US exposure. Could you rank them in order of preference for purchasing now? Any you’d avoid buying now?

BNS, SLF, PLC, MG, LAC, REAL, TFII, NVDA.US, ROKU.US, SQ.US

Thanks for your great work and please feel free to dock me for two questions.

Chris
Read Answer Asked by Christopher on March 22, 2021
Q: I received a large booklet about Sangoma dealings with StarBlue, Is the stock still worth holding? You had previously recommended it.
Apple seems to be a has-been - should I move on to other performing tech stocks?
Where can I look for the dates for upcoming earnings reports? Where are they easily accessible? Thank you.
Read Answer Asked by Dennis on March 15, 2021
Q: Hi, I am a holder and have had the recent pleasure of walking through the Sangoma Proxy materials and have read more about the deal with StarBlue and I'm wondering your thoughts of the transaction, specifically around the details that the StarBlue CEO will be THE major holder of Sangoma (25%). I understand that Sangoma is using their much better capital position to expand and magically double their revenue and garner much more SaaS ARR, however, it feels like the StarBlue organization was far less diligent in their balance sheet management and overall operations. Do you feel the Sangoma management will actually be able to exert their clearly quite strong operational 'chops' on StarBlue? It sort of feels like a reverse buy; As in, StarBlue convinced Sangoma to 'buy' them and thus give them capital, but the actual ownership is with StarBlue.
Read Answer Asked by Allan on March 12, 2021
Q: Hello,
I have new money to allocate. Which ones of these are your favorites for 5 year + hold notwithstanding they have different risk profile and in different sectors (best overall risk / reward. I am underweight small cap). I already own KXS and ENGH but i could add to existing positions. Thank you!
Read Answer Asked by Pierre on February 25, 2021
Q: I am looking for high growth ideas from small caps. From this list, what would be your TOP 3 Picks?

Thanks Valter
Read Answer Asked by Valter on February 16, 2021
Q: I have 3.5% if funds specifically earmarked for the technology sector after recently selling a position in OTEX. I am debating between taking a 3.5% position in CSU or splitting the funds and taking two smaller positions in STC and PHO. My portfolio consists mainly of larger market cap, lower volatility investments, so I feel I have some flexibility towards taking on a position in growth companies. That being said, I believe that CSU is best-in-class for its sector (particularly if limiting the field to TSX-traded companies). I would appreciate your insight. Thanks so much!
Read Answer Asked by Domenic on February 11, 2021
Q: Hi,
Can you please suggest 2-4 stocks in the Canada Tech industry in the short to mid-term?
Read Answer Asked by Mintu on February 08, 2021
Q: Peter; I asked their investor relations department re hold up- the below is his reply. Hello Rod
As shared in last Friday's Sangoma has signed an agreement to buy a
company called Star2Star https://www.sangoma.com/investor-relations/
The transaction meets the criteria for review by our exchange, the TSX-V,
and we submitted the necessary documents on January 29th. In the course
of their review the TSX-V may ask questions which the company will answer
but the timetable is governed by the exchange so we don't know exactly
when they will complete their review such that trading can recommence.
Regards
David
Read Answer Asked by Rodney on February 04, 2021
Q: With the recent acquisition, it seems that Sangoma is issuing 22 million shares now, and then an enormous number of shares (88 million) issued in slow quarterly chunks between 2022 and 2026 to the acquired company. How will this affect the share price in the future, ie. are these going to be quarterly share price dilutions that current shareholders need to dread? Or overhangs? Please explain.
Read Answer Asked by Michael on February 01, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!